The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria

Lori M.B. Laffel; Janet B. McGill; Daniel J. Gans

doi:10.1016/S0002-9343(99)80226-5

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria

Lori M.B. Laffel
, Janet B. McGill
, Daniel J. Gans

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	497-504
Number of pages	8
Journal	The American journal of medicine
Volume	99
Issue number	5
DOIs	https://doi.org/10.1016/S0002-9343(99)80226-5
State	Published - Nov 1995

Access to Document

10.1016/S0002-9343(99)80226-5

Cite this

@article{e3b7002f5fb54b288a4eb053ec3b62ab,

title = "The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria",

author = "Laffel, \{Lori M.B.\} and McGill, \{Janet B.\} and Gans, \{Daniel J.\}",

note = "Funding Information: From the Epidemiology and Genetics Unit (LMBL), Research Division, Youth Unit, Clinic Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts; Division of Endocrinology (JBM), Department of Medicine, Washington University, St. Louis, Missouri; Bristol-Myers Squibb Co. (DJG), Princeton, New Jersey. {\textquoteleft}Participating centers and investigators in the North American Microalbuminuria Study Group are listed in the Appendix. This study was supported by a grant from the Bristol-Myers Squibb Institute for Pharmaceutical Research, Princeton, New Jersey. They did not have access to unblinded data. Requests for reprints should be addressed to Dr. Laffel, Joslin Diabetes Center, One Joslin Place, Boston, Massachusetts 02215. Manuscript submltted November 10, 1994 and accepted in revised form February 23, 1995.",

year = "1995",

month = nov,

doi = "10.1016/S0002-9343(99)80226-5",

language = "English",

volume = "99",

pages = "497--504",

journal = "The American journal of medicine",

issn = "0002-9343",

number = "5",

}

TY - JOUR

T1 - The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria

AU - Laffel, Lori M.B.

AU - McGill, Janet B.

AU - Gans, Daniel J.

N1 - Funding Information: From the Epidemiology and Genetics Unit (LMBL), Research Division, Youth Unit, Clinic Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts; Division of Endocrinology (JBM), Department of Medicine, Washington University, St. Louis, Missouri; Bristol-Myers Squibb Co. (DJG), Princeton, New Jersey. ‘Participating centers and investigators in the North American Microalbuminuria Study Group are listed in the Appendix. This study was supported by a grant from the Bristol-Myers Squibb Institute for Pharmaceutical Research, Princeton, New Jersey. They did not have access to unblinded data. Requests for reprints should be addressed to Dr. Laffel, Joslin Diabetes Center, One Joslin Place, Boston, Massachusetts 02215. Manuscript submltted November 10, 1994 and accepted in revised form February 23, 1995.

PY - 1995/11

Y1 - 1995/11

UR - https://www.scopus.com/pages/publications/0028860451

U2 - 10.1016/S0002-9343(99)80226-5

DO - 10.1016/S0002-9343(99)80226-5

M3 - Article

C2 - 7485207

AN - SCOPUS:0028860451

SN - 0002-9343

VL - 99

SP - 497

EP - 504

JO - The American journal of medicine

JF - The American journal of medicine

IS - 5

ER -

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria

Access to Document

Other files and links

Cite this